Literature DB >> 24726144

Asymptomatic carotid stenosis and cognitive improvement using transcervical stenting with protective flow reversal technique.

G Ortega1, B Alvarez2, M Quintana3, X Yugueros2, J Alvarez-Sabin3, M Matas2.   

Abstract

OBJECTIVES: The relationship between carotid artery stenosis and cognitive function in individuals without a history of stroke is not clear. The possible pathomechanisms of cognitive impairment include silent embolization and hypoperfusion. In this study the aim was to assess cognitive changes after transcervical carotid artery stenting with proximal cerebral protection by flow reversal in patients with asymptomatic carotid stenosis, a novel technique that has been proved to decrease the number intraoperative emboli.
METHODS: 25 consecutive patients were assessed, of which 22 were men (88%) mean age of 74 years with severe asymptomatic carotid stenosis who underwent revascularization by carotid artery stenting (CAS) with flow reversal. Patients were evaluated 1 day before and 6 months after the procedure using a standardized neuropsychological battery. Test scores were adjusted according to age, sex, education level and were standardized (0-100). The mean of all the cognitive function scores yielded the global cognitive score (GCS).
RESULTS: There were no neurological complications during the procedure or during hospitalization in any patient. No deaths or cardiac complications occurred in any patient. The pre-procedure neuropsychological study showed cognitive impairment in: information processing speed in 15 patients (62.5%), visuospatial function in 14 (56.0%), memory in 18 (72.0%), executive functions in 14 (56.0%), language in three (12.0%), attention in 10 (40.0%), and global cognitive performance in eight (32.0%). Comparison of these scores with those obtained 6-month post-procedure showed significant improvement in GCS in all patients (p = .002), with a particularly marked gain in information processing speed (p = .018). Although significant improvement was not found for the remaining cognitive functions assessed, some gain was documented, and there was no deterioration.
CONCLUSIONS: Revascularization by transcervical CAS with flow reversal for cerebral protection results in improved neurocognitive performance in asymptomatic elderly patients with severe carotid artery stenosis.
Copyright © 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asymptomatic stenosis; Carotid stenting; Cognition; Neuropsychological improvement

Mesh:

Year:  2014        PMID: 24726144     DOI: 10.1016/j.ejvs.2014.02.022

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  4 in total

1.  Intervention versus Aggressive Medical Therapy for Cognition in Severe Asymptomatic Carotid Stenosis.

Authors:  C-J Lin; F-C Chang; K-H Chou; P-C Tu; Y-H Lee; C-P Lin; P-N Wang; I-H Lee
Journal:  AJNR Am J Neuroradiol       Date:  2016-04-28       Impact factor: 3.825

2.  Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients.

Authors:  Omar Abdul-Jawad Altisent; Ignacio Ferreira-Gonzalez; Josep R Marsal; Aida Ribera; Cristina Auger; Gemma Ortega; Purificación Cascant; Marina Urena; Bruno Garcia Del Blanco; Vicenç Serra; Carlos Sureda; Albert Igual; Alex Rovira; María Teresa González-Alujas; Anna Gonzalez; Rishi Puri; Hug Cuellar; Pilar Tornos; Josep Rodés-Cabau; David Garcia-Dorado
Journal:  Clin Res Cardiol       Date:  2015-12-08       Impact factor: 5.460

3.  Markers of arterial health could serve as accurate non-invasive predictors of human biological and chronological age.

Authors:  Alexander Fedintsev; Daria Kashtanova; Olga Tkacheva; Irina Strazhesko; Anna Kudryavtseva; Ancha Baranova; Alexey Moskalev
Journal:  Aging (Albany NY)       Date:  2017-04       Impact factor: 5.682

Review 4.  Is Hemispheric Hypoperfusion a Treatable Cause of Cognitive Impairment?

Authors:  Amani M Norling; Randolph S Marshall; Marykay A Pavol; George Howard; Virginia Howard; David Liebeskind; John Huston; Brajesh K Lal; Thomas G Brott; Ronald M Lazar
Journal:  Curr Cardiol Rep       Date:  2019-01-19       Impact factor: 2.931

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.